Autism Spectrum Disorder Trial, Recruiting (NCT06845488)

Autism Spectrum Disorder Trial, Recruiting NCT06845488 Sponsor: The University of Texas Health Science Center, Houston Condition: Autism Spectrum Disorder

Printed from Voxsanity (voxsanity.com.au) — NCT06845488 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Autism Spectrum Disorder

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with Autism Spectrum Disorder (ASD) by a qualified professional
People who can speak and read in English or Spanish
People with average or higher intellectual ability, based on personal history and an interview
People who are able to use a Windows or Mac computer

Who may not be able to join:

People who have, or have previously had, a severe mental illness such as schizophrenia, bipolar disorder, or severe depression
People with an intellectual disability or learning disability that would make participation difficult (for example, difficulty with reading)
People who are not able to use the required technology, or do not have access to it
People who are not able to read

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Katherine Loveland, PhD, The University of Texas Health Science Center at Houstom

Phone: 713-486-2587

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06845488

Sponsor: The University of Texas Health Science Center, Houston

Phase: Not Applicable

Status: Recruiting

Condition: Autism Spectrum Disorder

Trial contact: 713-486-2587

More information: https://clinicaltrials.gov/study/NCT06845488

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with Autism Spectrum Disorder (ASD) by a qualified professional
People who can speak and read in English or Spanish
People with average or higher intellectual ability, based on personal history and an interview
People who are able to use a Windows or Mac computer

Who may not be able to join:

People who have, or have previously had, a severe mental illness such as schizophrenia, bipolar disorder, or severe depression
People with an intellectual disability or learning disability that would make participation difficult (for example, difficulty with reading)
People who are not able to use the required technology, or do not have access to it
People who are not able to read

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

The University of Texas Health Science Center, Houston

Registry

ClinicalTrials.gov

Start date

7 November 2024

Est. completion

1 March 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in anxiety as assessed by the Liebowitz Social Anxiety Scale (LSAS); Change in anxiety as assessed by the Social Interaction Anxiety Scale (SIAS); Change in anxiety as assessed by the Social Phobia Scale (SPS); Change in anxiety as assessed by the The Severity Measure for Social Anxiety Disorder (SMSAD) scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov